Journal of Electrocardiology
Volume 43, Issue 5 , Pages 386-389, September 2010

Drug-induced QT interval shortening: an emerging component in integrated assessment of cardiac safety of drugs☆☆☆

  • Rashmi R. Shah, MBBS, MD, FRCP, FFPM

      Affiliations

    • The views expressed in this article are those of the authors and do not necessarily reflect the views or opinions of the MHRA, other regulatory authorities, or any of the regulatory advisory bodies or the affiliate institutions of the authors.

Rashmi Shah Consultancy Ltd, Gerrards Cross, UK

Washington University in St. Louis, USA

NewCardio, Inc, Princeton, NJ USA

Robert Wood Johnson Medical School, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Conflict of interest: none. The authors did not receive any financial support from any source in the preparation of this editorial.

☆☆ The views expressed in this article are those of the authors and do not necessarily reflect the views or opinions of the MHRA, other regulatory authorities, or any of the regulatory advisory bodies or the affiliate institutions of the authors.

PII: S0022-0736(10)00272-4

doi:10.1016/j.jelectrocard.2010.06.008

Journal of Electrocardiology
Volume 43, Issue 5 , Pages 386-389, September 2010

Article Tools